WHO ICTRP trial
The role of D-Cycloserine in combination with exposure therapy in the treatment…
ACTRN12606000351516 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12606000351516 |
|---|---|
| Public title | The role of D-Cycloserine in combination with exposure therapy in the treatment of Panic Disorder to improve the severity of panic symptoms. |
| Scientific title | A randomised controlled trial to evaluate the effects of D-Cycloserine in combination with Exposure Therapy in the treatment of panic disorder to improve the severity of Panic Symptoms |
| Primary sponsor | University of New South Wales |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Countries | Australia |
| Conditions | Panic Disorder; Panic Disorder;Mental Health - Other mental health disorders |
| Interventions | D-Cycloserine and Exposure Therapy. Participants are given 3 weekly sessions (once per week) of group-based exposure therapy. One group of participants receives D-Cycloserine (50mg) before each therapy session. Each dose is given orally in… |
| Registration date | Aug 16, 2006 |
| Target size | 30 |
| Secondary IDs | Human Research Ethics Committee (HREC): HREC 04145;Clinical Trial Notification (CTN): 2004/443 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: